Literature DB >> 2861256

Cat retinal ganglion cell receptive-field alterations after 6-hydroxydopamine induced dopaminergic amacrine cell lesions.

G W Maguire, E L Smith.   

Abstract

Optic tract single-unit recordings were used to study ganglion cell response functions of the intact cat eye after 6-hydroxydopamine (6-OHDA) lesioning of the dopaminergic amacrine cell (AC) population of the inner retina. The impairment of the dopaminergic AC was verified by high pressure-liquid chromatography (HPLC) with electrochemical detection of endogenous dopamine content and by [3H]dopamine high-affinity uptake; the dopaminergic ACs of the treated eyes demonstrated reduced endogenous dopamine content and reduced [3H]dopamine uptake compared with that of their matched controls. Normal appearing [3H]GABA and [3H]-glycine uptake in the treated retinas suggests the absence of any nonspecific action of the 6-OHDA on the neural retina. The impairment of the dopaminergic AC population was found to alter a number of response properties in off-center ganglion cells, but this impairment had only a modest effect on the on-center cells. An abnormally high proportion of the off-center ganglion cells in the 6-OHDA treated eyes possessed nonlinear, Y-type receptive fields. These cells also possessed shift-responses of greater than normal amplitude, altered intensity-response functions, reduced maintained activities, and more transient center responses. Of the on-center type cells, only the Y-type on-center cells were affected by 6-OHDA, possessing higher than normal maintained activities and altered intensity-response functions. The on-center X-cells were unaffected by 6-OHDA treatment. The dopaminergic AC of the photopically adapted cat retina therefore modulates a number of ganglion cell response properties and within the limits of this study is most prominent in off-center ganglion cell circuitry. When functioning normally, the dopaminergic AC of the cat's retina appears to make the receptive field of the off-center cell more sustained and may make its spatial summation characteristics more linear while adjusting the intensitive properties of neurons in both the on- and off-center pathways.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2861256     DOI: 10.1152/jn.1985.53.6.1431

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  7 in total

1.  Effects of dopamine depletion on visual sensitivity of zebrafish.

Authors:  L Li; J E Dowling
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

2.  Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials.

Authors:  I Gottlob; H Weghaupt; C Vass; E Auff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

3.  Analysis of cat retina for dopamine, dihydroxyphenylacetic acid, 3-methoxytyramine and homovanillic acid.

Authors:  D M Vaughn; D M Lindley; N R Cox; S T Simpson; W L Whitmer
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

4.  Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease.

Authors:  J Nguyen-Legros
Journal:  Surg Radiol Anat       Date:  1988       Impact factor: 1.246

5.  Intravitreally-administered dopamine D2-like (and D4), but not D1-like, receptor agonists reduce form-deprivation myopia in tree shrews.

Authors:  Alexander H Ward; John T Siegwart; Michael R Frost; Thomas T Norton
Journal:  Vis Neurosci       Date:  2017-01       Impact factor: 3.241

6.  Inhibitory components of retinal bipolar cell receptive fields are differentially modulated by dopamine D1 receptors.

Authors:  Reece E Mazade; Erika D Eggers
Journal:  Vis Neurosci       Date:  2020-02-12       Impact factor: 3.241

7.  Mechanisms creating transient and sustained photoresponses in mammalian retinal ganglion cells.

Authors:  Xiwu Zhao; Aaron N Reifler; Melanie M Schroeder; Elizabeth R Jaeckel; Andrew P Chervenak; Kwoon Y Wong
Journal:  J Gen Physiol       Date:  2017-02-02       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.